Features of some transcription factors gene expression in the malignancy tissues of the corpus uteri

Cover Page

Cite item

Full Text

About the authors

D. S. Kutilin

Rostov Research Institute of Oncology, Ministry of Health of Russia

Author for correspondence.
Email: k.denees@yandex.ru
ORCID iD: 0000-0002-8942-3733

63 14th Line, Rostov-on-Don 344037.

Russian Federation

I. S. Nikitin

Rostov Research Institute of Oncology, Ministry of Health of Russia

Email: fake@neicon.ru

63 14th Line, Rostov-on-Don 344037.

Russian Federation

O. I. Kit

Rostov Research Institute of Oncology, Ministry of Health of Russia

Email: fake@neicon.ru
ORCID iD: 0000-0003-3061-6108

63 14th Line, Rostov-on-Don 344037.

Russian Federation

References

  1. Kit O.I., Vodolazhsky D.I., Kutilin D.S. Aberrant transcriptional activity of apoptosis-regulating genes in malignant neoplasm of corpus uteri. Molekulyarnaya meditsina = Molecular Medicine 2018;16(1):25—31 (In Russ.).
  2. Pitynski K., Banas T., Pietrus M. et al. SOX-2, but not Oct4, is highly expressed in early-stage endometrial adenocarcinoma and is related to tumour grading. Int J Clin Exp Pathol 2015;8(7):8189—98.
  3. Kit O.I., Vodolazhsky D.I., Kutilin D.S. et al. Changes in expression of estrogen-regulatory genes in malignancy uterine tis¬sues. Kubanskiy nauchnyy meditsinskiy vestnik = Kuban Scientific Medical Bulletin 2016;(2):84—90. (In Russ.).
  4. Zhu C.Q., Shih W., Ling C.H., Tsao M.S. Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation. J Clin Pathol 2006;59(8):790-800. doi: 10.1136/jcp.2005.031351. PMID: 16873561.
  5. Chen Z., Xu W.R., Qian H. et al. Oct4, a novel marker for human gastric cancer. J Surg Oncol 2009;99(7):414—19. doi: 10.1002/jso.21270. PMID: 19347886.
  6. Masui S., Nakatake Y., Toyooka Y. et al. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol 2007;9(6):625—35. doi: 10.1038/ncb1589. PMID: 17515932.
  7. Gearhart J., Pashos E.E., Prasad M.K. Pluripotency redux — advances in stem-cell research. N Engl J Med 2007;357(15):1469—72. doi: 10.1056/NEJMp078126. PMID: 17928593.
  8. Chen Y., McGee J., Chen X. et al. Identification of druggable cancer driver genes amplified across T CGA datasets. PLoS One 2014;9(5):e98293. doi: 10.1371/journal.pone.0107646. PMID: 24874471.
  9. Kit O.I., Vodolazhsky D.I., Kutilin D.S. et al. Method of recurrent endometrial cancer prediction based on PTEN and CYP1B1 genes expression level. Patent for invention RUS 2605302, 10.11.2015. (In Russ.).
  10. Kutilin D.S. Molecular mechanisms for the implementation of geroprotective activity of the delta-sleep peptide. Author’s abstract of thesis ... of candidate iological sciences: 03.01.04. South Federal University. Rostov-on-Don, 2013. (In Russ.).
  11. Kit O.I., Vodolazhsky D.I., Dimitriadi S.N. et al. The activity of proapoptotic genes increases after renal ischemia/reperfusion. Molekulyarnaya biologiya = Molecular Biology 2017;51(3):445—52. (In Russ.).
  12. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25(4):402-8. doi: 10.1006/meth.2001.1262. PMID: 11846609.
  13. Hubbard S., Gargett C. A cancer stem cell origin for human endometrial carcinoma? Reproduction 2010;140(1):23—32. doi: 10.1530/REP-09-0411. PMID: 20089663.
  14. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126(4):663-76. doi: 10.1016/j.cell.2006.07.024. PMID: 16904174.
  15. Rizzino A. The Sox2-Oct4 connection: critical players in a much larger interdependent network integrated at multiple levels. Stem Cells 2013;31(6):1033—9. doi: 10.1002/stem.1352. PMID: 23401375.
  16. You L., Guo X., Huang Y. Correlation of cancer stem-cell markers OCT4, SOX2, and NANOG with clinicopathological features and prognosis in operative patients with rectal cancer. Yonsei Med J 2017;59(1):35—42. doi: 10.3349/ymj.2018.59.1.35. PMID: 29214774.
  17. Hatefi N., Nouraee N., Parvin M. et al. Evaluating the expression of OCT4 as a prognostic tumor marker in bladder cancer. Iran J Basic Med Sci 2012;15(6):1154—61. PMID: 23653844.
  18. Lee C.J., Sung P.L., Kuo M.H. et al. Crosstalk between SOX2 and cytokine signaling in endometrial carcinoma. Sci Rep 2018;8(1):17550. doi: 10.1038/s41598-018-35592-0. PMID: 30510261.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c)


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 57560 от  08.04.2014.